Oncology Hematology West P.C. dba Nebraska Cancer Specialists — Omaha, Nebraska

Oncology Hematology West P.C. dba Nebraska Cancer Specialists is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Oncology Hematology West P.C. dba Nebraska Cancer Specialists has participated in 14 clinical trials with 8 currently active.

Therapeutic areas: Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Melanoma Stage III, Melanoma Stage IV.

Sponsors: Bristol-Myers Squibb, BioNTech SE, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Hematology West P.C. dba Nebraska Cancer Specialists?

Oncology Hematology West P.C. dba Nebraska Cancer Specialists has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Hematology West P.C. dba Nebraska Cancer Specialists conducted?

Oncology Hematology West P.C. dba Nebraska Cancer Specialists has 14 clinical trials on record, with 8 currently active. Their work covers Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Melanoma Stage III, Melanoma Stage IV.

Is Oncology Hematology West P.C. dba Nebraska Cancer Specialists accredited by Crixeo Health?

Oncology Hematology West P.C. dba Nebraska Cancer Specialists has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology Hematology West P.C. dba Nebraska Cancer Specialists?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.